The incidence of narcolepsy in Europe: Before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns

Author(s):
Wijnans, L.; Lecomte, C.; Vries, C. de; Weibel, D.; Sammon, C.; Hviid, A.; Svanstrom, H.; Molgaard-Nielsen, D.; Heijbel, H.; Dahlstrom, L.A.; Hallgreng, J.; Sparen, P.; Jennum, P.; Mosseveld, M.; Schuemie, M.; Maas, N. van der; Partinen, M.; Romio, S.; Trotta, F.; Santuccio, C.; Menna, A.; Plazzi, G.; Moghadam, K.K.; Ferro, S.; Lammers, G.J.; Overeem, S.; Johansen, K.; Kramarz, P.; Bonhoeffer, J.; Sturkenboom, M.C.J.M.
Published
2013
Publication type
Article / Letter to editor
NarcolepsyIncidenceBackground ratesInfluenza vaccineASO3B adjuvant
Date issued
2013-02-06
Language
English
Is part of
Vaccine (2013), Vol. 31, no. 8, p. 1246-1254
hdl
1887/102938
doi
10.1016/j.vaccine.2012.12.015